Oncolytic biotherapy: a novel therapeutic platform
- 1 January 2002
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 3 (1), 17-26
- https://doi.org/10.1016/s1470-2045(01)00618-0
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regressionGene Therapy, 2000
- A tale of two trials: selectively replicating herpesviruses for brain tumorsGene Therapy, 2000
- Gene delivery from replication-selective viruses: arming guided missiles in the war against cancerJCI Insight, 2000
- Use of preferentially replicating bacteria for the treatment of cancerJCI Insight, 2000
- Poxvirus vectors: orphaned and underappreciatedJCI Insight, 2000
- Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumorsGene Therapy, 1998
- Construction and Characterization of a Recombinant Vaccinia Virus Expressing Murine Intercellular Adhesion Molecule-1: Induction and Potentiation of Antitumor ResponsesHuman Gene Therapy, 1997
- A Novel Gene Therapy Strategy for Elimination of Prostate Carcinoma Cells from Human Bone MarrowHuman Gene Therapy, 1997
- Cancer Cell CyclesScience, 1996
- Adenovirus 2 lp+ locus codes for a 19 kd tumor antigen that plays an essential role in cell transformationCell, 1983